MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
Naoto Muraoka(Keio University), Masaki Ieda(University of Tsukuba), Hanae Nakashima(Keio University), Mizuha Akiyama(Keio University), Ruri Kaneda(Jichi Medical University), Kohei Inagawa(Keio University), Yoshifumi Kawamura(Tohoku University), Mari Isomi(Keio University), Naoki Goshima(National Institute of Advanced Industrial Science and Technology), Tomohiko Umei(Keio University Hospital), Keiichi Fukuda(Keio University Hospital), Rie Wada(Keio University), Takahiko Nishiyama(Keio University), Hiroyuki Yamakawa(Keio University), Hiroyuki Yamagishi(Tokyo Metropolitan Children's Medical Center), Shugo Tohyama(Fujita Health University), Taketaro Sadahiro(Keio University), Shu Takeda(Toranomon Hospital), Kazutaka Miyamoto(Saitama Municipal Hospital), Ryo Aeba(Keio University), Toru Fukuda(Saitama Medical University), Hisayuki Hashimoto(Keio University)
Cited by 302
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Cardiac Innervation and Sudden Cardiac Death
|Circulation Research|2015|391
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
|Nature|2011|388
Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Interventions|2012|381